期刊文献+

补充叶酸对溃疡性结肠炎相关结直肠癌和非典型性增生发病风险影响的Meta分析 被引量:3

Effect of Folic Acid Supplementation on the Risk of Cancer and Atypical Dysplasia in Ulcerative Colitis: A Meta-analysis
下载PDF
导出
摘要 目的评价补充叶酸对溃疡性结肠炎(UC)相关结直肠癌和非典型性增生发病风险的影响。方法计算机检索Cochrane图书馆、PubMed、EMBase、ISI数据库、中国期刊全文数据库、中文科技期刊数据库和万方数据库,检索时间从建库至2012年12月;同时手工检索相关文献的参考文献及国内外重要胃肠病会议摘要。筛选补充叶酸与UC相关结直肠癌和非典型性增生关系相关的研究,由2名研究者独立进行资料提取与文献质量评价。应用RevMan 5.2统计软件进行Meta分析,合并效应量为比值比(OR)。结果最终共纳入4个符合标准的研究,其中发生UC相关结直肠癌和非典型性增生88例(病例组),未发生UC相关结直肠癌和非典型性增生223例(对照组)。病例组补充叶酸者20例,对照组补充叶酸者94例,Meta分析结果显示,补充叶酸者UC相关结直肠癌和非典型性增生发生率低于未补充叶酸者〔OR=0.40,95%CI(0.22,0.70),P=0.002〕。结论补充叶酸有助于降低UC相关结直肠癌和非典型性增生发生率。 Objective To evaluate the influence of folic acid supplementation on the ulcerative colitis(UC)-associated colorectal cancer and atypical dysplasia.Methods Computer-assisted searches of the Cochrane Database,PubMed,EMBase,ISI Database,Full-text Database of Chinese Journals,Chinese Sci-tech Journal Database,and Wanfang database from the inception of each database to December 2012 were used to identify all available studies.Meanwhile,manual searches of literature references and abstracts of the important domestic or international gastroenterology meetings were utilized to obtain relevant studies.Articles involving effects of folic acid supplementation on the risk of UC-associated colorectal cancer and dysplasia were screened by two independent reviewers.The data extraction and quality assessment were implemented independently.The meta-analysis was performed by using Review Manager 5.2 software,with calculation of the odds ratio(OR) and its 95% confidence interval(CI).Results Four studies involving 88 cases of UC-associated colorectal cancer or dysplasia and 223 controls were included in the study.Twenty cases in the case group and 94 cases in the control group had folic acid supplementation.Meta-analysis showed that the incidence of UC-associated colorectal cancer and dysplasia was lower in cases with folic acid supplementation than in those without 〔OR = 0.40,95% CI(0.22,0.70),P = 0.002〕.Conclusion Folic acid supplementation can reduce the incidence of UC-associated colorectal cancer and dysplasia.
出处 《中国全科医学》 CAS CSCD 北大核心 2013年第20期2374-2376,共3页 Chinese General Practice
基金 贵阳市社会发展与民生科技计划项目(筑科合同[2012103]50号)
关键词 叶酸 结肠炎 溃疡性 META分析 Folic acid Colitis ulcerative Meta-analysis
  • 相关文献

参考文献17

  • 1樊慧丽,陈玉梅.溃疡性结肠炎的发病机制和治疗进展[J].中国全科医学,2012,15(2):228-230. 被引量:99
  • 2Danese S, Fioechi C. Ulcerative colitis [J]. N Eng! J Med, 2011, 365 (18): 1713 -1725.
  • 3Biasco G, Di Marco MC. Folate and prevention of colorectal cancer in ulcerative colitis [J]. Eur J Cancer Prev , 2005, 14 (4): 395 - 398.
  • 4Baggott JE, Oster RA, Tamura T. Meta - analysis of cancer risk in fo?lic acid supplementation trials [J] . Cancer Epidemiol , 2012, 36 (1): 78 -81.
  • 5Higgins JFT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5. O. 0 [EB/OLJ. Updated February, 2008, The Cochrane Collaboration.
  • 6Lashner BA, Heidenreich PA, Su GL, et al. Effect of folate supple?mentation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case - control study [J] . Gastroenterology, 1989, 97 (2): 255 -259.
  • 7Lashner BA. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis [J]. J Cancer Res Clin On?col, 1993, 119 (9): 549 -554.
  • 8Lashner BA, Provencher KS, Seidner DL, et al. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative coli?tis [JJ. Gastroenterology, 1997, 112 (1): 29 -32.
  • 9Tang J, Sharif 0, Pai C, et al. Mesalamine protects against colorectal cancer in inflammatory bowel disease [J]. Dig Dis Sci, 2010, 55 (6): 1696 -1703.
  • 10Jess T, Rungoe C, Peyrin - Biroulet 1. Risk of colorectal cancer in patients with ulcerative colitis: a meta - analysis of population - based cohort studies [J]. Clin Gastroenterol Hepatol, 2012, 10 (6): 639 -645.

二级参考文献81

共引文献168

同被引文献72

  • 1柴瑞婷,贾育新,张明雨,范珉珏,康永强,刘金平.贾育新教授应用参苓白术散化裁治疗溃疡性结肠炎临证经验[J].亚太传统医药,2020(11):89-91. 被引量:4
  • 2徐希民,管纯梅,孙建丽,李朱福,诸月琴.血清维生素A和维生素C水平与大肠癌发病关系的探讨[J].实用肿瘤杂志,1989,4(3):153-155. 被引量:3
  • 3杨工,高玉堂,季步天,金凡,高汝聂,郑树.结、直肠癌与营养因素的流行病学研究[J].中华流行病学杂志,1994,15(5):299-303. 被引量:31
  • 4吴晓锐,张锋,詹志刚,郑林.赛庚啶联合双歧三联活菌胶囊治疗腹泻型肠易激综合征疗效观察[J].临床军医杂志,2006,34(3):284-285. 被引量:1
  • 5Muzny DM,Bainbridge MN,Chang K,et al.Comprehensive molecular characterization of human colon and rectal cancer[J].Nature,2012,487(7407):330-337.
  • 6Courtney RJ,Paul CL,Carey ML,et al.A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients[J].BMC Cancer,2013,13(1):1-11.
  • 7Dahan L,Norguet E,Etienne-Grimaldi MC,et al.Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer[J].BMC Cancer,2011,11(1):496.
  • 8Adelsten BA,Dobbins TA,Harris CA,et al.A systematic review and meta-analysis of KRAS status as determinant of response to anti-EGFR antibodies and impact of partner chemotherapy in metastatic colorectal cancer[J].Eur J Cancer,2011,47(9):1343-1354.
  • 9Lin AY,Buckley NS,Lu AT,et al.Effect of KRAS mutational status in advanced colorectal cancer on the outcomes of anti-epidermal growth factor receptor monoclonal antibody therapy:a systematic review and meta-analysis[J].Clin Colorectal Cancer,2011,10(1):63-69.
  • 10Greenwald P,Lanza E,Eddy GA,et al.Dietary fiber in the reduction of colon cancer risk[J].J Am Diet Assoc,1987,87(9):1178-1188.

引证文献3

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部